Add Company
Join Now

ProfoundBio Revenue and Competitors

License our Company Data API

Seattle, WA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ProfoundBio's estimated annual revenue is currently $1.9M per year.(i)
  • ProfoundBio's estimated revenue per employee is $155,000

Employee Data

  • ProfoundBio has 12 Employees.(i)
  • ProfoundBio grew their employee count by -73% last year.

ProfoundBio's People

NameTitleEmail/Phone
1
Chief Operating Officer Chief Financial OfficerReveal Email/Phone
2
Chief Business OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M60%N/AN/A
#3
$3.3M4310%$101MN/A
#4
$5.7M3712%N/AN/A
#5
$7M4541%N/AN/A
#6
$1.7M22-8%N/AN/A
#7
$3.9M504%$10.1MN/A
#8
$1.9M12-73%N/AN/A
#9
$29.3M151-17%$148MN/A
#10
$2M1386%N/AN/A
Add Company

What Is ProfoundBio?

ProfoundBio is a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on internally developed, innovative, and proprietary technology platforms, ProfoundBio has developed a pipeline consisting of multiple antibody-drug conjugate (ADC) drug candidates targeting solid tumors and hematological malignancies that are in discovery, preclinical, and clinical development stages. The Company’s clinical stage programs are rinatabart sesutecan (Rina-S; PRO1184), an ADC targeting folate receptor alpha, PRO1160, an ADC targeting CD70, and PRO1107, an ADC targeting PTK7. ProfoundBio is headquartered in Seattle, WA, USA.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.9M

Revenue (est)

-73%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M138%N/A
#2
$1.2M1475%N/A
#3
$1.3M15-12%N/A
#4
$1.7M16-16%N/A
#5
$1.5M17-19%N/A